YAO, Xiao Jun,LEUNG, Lai Han Elaine,LIU, Liang,FAN, Xing Xing,XIE, Chun
申请号：
AU2017101044
公开号：
AU2017101044A4
申请日:
2017.08.01
申请国别(地区):
AU
年份:
2017
代理人:
摘要：
#$%^&*AU2017101044A420170831.pdf#####ABSTRACT One example embodiment relates to a method of treating non-small cell lung cancer by administering a compound of formula (I) to a patient. Another example embodiment relates to a method of inhibiting progress of tumor growth in a patient with cancer, wherein tumor cells of the cancer have a mutant V-Kiras2 Kirsten rat sarcoma viral oncogene homolog (KRAS) gene, and the method includes administering to the patient the compound with the following formula I: H N HN oc'i F formula I. 5 19
